These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 8575232
1. Quantitation of P53 protein expression in gastrointestinal smooth muscle tumors. Clinicopathological correlation and prognostic significance. Cai J, Jiang Y, Zhang Y, Lu G, Zhang X, Gao Q, Zuo L. Chin Med J (Engl); 1995 Sep; 108(9):669-73. PubMed ID: 8575232 [Abstract] [Full Text] [Related]
2. [Flow cytometric quantitation of p53 protein expression in gastrointestinal smooth muscle tumors: clinicopathological correlation and prognostic significance]. Cai JH, Jiang YK, Zhang YY. Zhonghua Wai Ke Za Zhi; 1994 Aug; 32(8):483-6. PubMed ID: 7882774 [Abstract] [Full Text] [Related]
3. [Quantitation of Ras p21 oncogene and DNA content of gastrointestinal smooth muscle tumors and prognostic significance]. Cai J, Jiang Y, Zhang Y. Zhonghua Wai Ke Za Zhi; 1995 Apr; 33(4):225-8. PubMed ID: 7587676 [Abstract] [Full Text] [Related]
4. Smooth muscle tumors of the gastrointestinal tract. Expression of ras P21 oncogene product and the association with clinicopathology. Cai JH, Jiang YK, Zhang YY, Lu GH, Zhang XH, Gao QZ, Zuo LF. Chin Med J (Engl); 1994 Sep; 107(9):683-7. PubMed ID: 7805461 [Abstract] [Full Text] [Related]
5. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K. J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039 [Abstract] [Full Text] [Related]
6. [Gastrointestinal smooth muscle tumors: a study of DNA content and the association with clinicopathology]. Cai J, Jiang Y, Zhang Y. Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):378-80. PubMed ID: 8732098 [Abstract] [Full Text] [Related]
7. [Expression of nm23 in gastrointestinal smooth muscle tumors and its relation to cell proliferative activity]. Wang Q, Sun W, Zhao Y, Wang M, Qin Y, Fu Y. Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):427-9. PubMed ID: 11825432 [Abstract] [Full Text] [Related]
8. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus. Jeffers MD, Farquharson MA, Richmond JA, McNicol AM. J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782 [Abstract] [Full Text] [Related]
9. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Bodner-Adler B, Bodner K, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K. J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038 [Abstract] [Full Text] [Related]
10. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus. Zhai YL, Nikaido T, Toki T, Shiozawa A, Orii A, Fujii S. Br J Cancer; 1999 Jul; 80(10):1658-64. PubMed ID: 10408415 [Abstract] [Full Text] [Related]
11. Correlation between DNA ploidy and clinical features in smooth muscle tumors of the gastrointestinal tract. Kimura H, Yonemura Y, Kadoya N, Kosaka T, Miwa K, Miyazaki I, Sawa T, Yoshimitsu S, Nishida Y, Kamata T. Anal Cell Pathol; 1993 Nov; 5(6):331-8. PubMed ID: 8305329 [Abstract] [Full Text] [Related]
14. p53 alterations in uterine leiomyosarcomas versus leiomyomas. de Vos S, Wilczynski SP, Fleischhacker M, Koeffler P. Gynecol Oncol; 1994 Aug; 54(2):205-8. PubMed ID: 8063247 [Abstract] [Full Text] [Related]
15. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, Thomas V, Ganguly SS, Grant C. J Surg Oncol; 2005 Sep 15; 91(4):243-52. PubMed ID: 16121348 [Abstract] [Full Text] [Related]
16. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas. Jeffers MD, Richmond JA, Macaulay EM. Mod Pathol; 1995 Sep 15; 8(7):701-4. PubMed ID: 8539225 [Abstract] [Full Text] [Related]
17. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Bodner-Adler B, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K. Gynecol Oncol; 2005 Jan 15; 96(1):62-6. PubMed ID: 15589581 [Abstract] [Full Text] [Related]
18. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Amada S, Nakano H, Tsuneyoshi M. Int J Gynecol Pathol; 1995 Apr 15; 14(2):134-42. PubMed ID: 8601525 [Abstract] [Full Text] [Related]
19. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Can B, Sökmensüer C. Hepatogastroenterology; 2003 Dec 15; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191 [Abstract] [Full Text] [Related]
20. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study. Bodner-Adler B, Nather A, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K. Gynecol Oncol; 2006 Oct 15; 103(1):186-9. PubMed ID: 16595146 [Abstract] [Full Text] [Related] Page: [Next] [New Search]